WMSA
AGIO icon

Weiss Multi-Strategy Advisers’s Agios Pharmaceuticals AGIO Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-16,000
Closed -$1.31M – 542
2018
Q1 		$1.31M Buy
16,000
+4,000
+33% +$309K 0.04% 388
2017
Q4 		$686K Buy
12,000
+2,000
+20% +$126K 0.02% 475
2017
Q3 		$668K Buy
+10,000
New +$601K 0.02% 407
2013
Q4 		– Sell
-80,500
Closed -$2.25M – 963
2013
Q3 		$2.25M Buy
+80,500
New +$2.22M 0.05% 325

Other funds holding AGIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Weiss Multi-Strategy Advisers's AGIO Position: Q2 2018 in Review

Weiss Multi-Strategy Advisers sold out of Agios Pharmaceuticals (AGIO) in Q2 2018, closing a stake of 16,000 shares — an estimated $1.31M sold.

Weiss Multi-Strategy Advisers first reported a position in AGIO in Q3 2013 and held it in 4 quarters. The position peaked at $2.25M in Q3 2013. 217 funds tracked by Wall St. Rank hold AGIO as of Q2 2018.

  • Weiss Multi-Strategy Advisers reported no remaining Agios Pharmaceuticals position as of Q2 2018 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 16,000 Agios Pharmaceuticals shares in Q2 2018, an estimated $1.31M.
  • Weiss Multi-Strategy Advisers first reported a position in Agios Pharmaceuticals in Q3 2013 and held it in 4 quarters.
  • Weiss Multi-Strategy Advisers's Agios Pharmaceuticals position peaked at $2.25M in Q3 2013.
  • 217 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2018.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q2 2018, filed 14 Aug 2018.